{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:34:31Z","timestamp":1781314471593,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40249-019-0574-0","type":"journal-article","created":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T23:02:24Z","timestamp":1563145344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The need for evidence-based strategies and tools for onchocerciasis elimination in Africa"],"prefix":"10.1186","volume":"8","author":[{"given":"Yankum","family":"Dadzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uche V.","family":"Amazigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boakye A.","family":"Boatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azodoga","family":"S\u00e9k\u00e9t\u00e9li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"574_CR1","unstructured":"Richard FO, Nwoke BEB, Zarroug I, Tukahebwa E, Negussu N, Higazi TB, et al. Response to Dadzie et al.: \u201cis onchocerciasis elimination in Africa feasible by 2025: the need for a broad perspective\u201d. Infect Dis Poverty. 2019; (In press)."},{"key":"574_CR2","doi-asserted-by":"crossref","unstructured":"Cupp E, Sauerbrey M, Cama V, Eberhard M, Lammie PJ, Unnasch TR. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective. Infect Dis Poverty. 2019; (In press).","DOI":"10.1186\/s40249-019-0557-1"},{"key":"574_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40249-018-0446-z","volume":"7","author":"Y Dadzie","year":"2018","unstructured":"Dadzie Y, Amazigo UV, Boatin BA, Seketeli A. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes. Infect Dis Poverty. 2018;7:63.","journal-title":"Infect Dis Poverty"},{"key":"574_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115886","volume":"9","author":"LE Coffeng","year":"2014","unstructured":"Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, de Vlas SJ. Elimination of african onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. PLoS One. 2014;9:e115886.","journal-title":"PLoS One"},{"key":"574_CR5","first-page":"20","volume-title":"Report of the consultative meetings on Strategic Options and Alternative Treatment Strategies for Accelerating Onchocerciasis Elimination in Africa","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Report of the consultative meetings on Strategic Options and Alternative Treatment Strategies for Accelerating Onchocerciasis Elimination in Africa. Geneva: African Programme for onchocerciasis control, World Health Organization, Document: WHO\/MG\/15; 2015. p. 20."},{"key":"574_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000497","volume":"3","author":"L Diawara","year":"2009","unstructured":"Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009;3:e497.","journal-title":"PLoS Negl Trop Dis"},{"key":"574_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001825","volume":"6","author":"MO Traore","year":"2012","unstructured":"Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6:e1825.","journal-title":"PLoS Negl Trop Dis"},{"key":"574_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006249","volume":"12","author":"KM Gass","year":"2018","unstructured":"Gass KM. Rethinking the serological threshold for onchocerciasis elimination. PLoS Negl Trop Dis. 2018;12:e0006249.","journal-title":"PLoS Negl Trop Dis"},{"key":"574_CR9","unstructured":"NTD Support Center: Ov-16 Meeting Notes [\n                    https:\/\/www.ntdsupport.org\/sites\/default\/files\/uploads\/docs\/resources\/Ov16%20Technical%20Meeting%20Report_May_2016.pdf\n                    \n                  ]. Accessed 26 March 2019."},{"key":"574_CR10","first-page":"64","volume-title":"Certification of elimination of human onchocerciasis: criteria and procedures","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Certification of elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization, Document: WHO\/CDS\/CPE\/CEE\/2001.18a; 2001. p. 64."},{"key":"574_CR11","unstructured":"OEPA. Guidelines for certifying elimination of human onchocerciasis in the Americas, including a discussion of critical issues. A document developed for discussion of approaches to certify elimination of human onchocerciasis. English version: 2000."},{"key":"574_CR12","unstructured":"World Health Organization. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures: World Health Organization, Document: WHO\/HTM\/NTD\/PCT\/2016.1. Geneva; 2016."},{"key":"574_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40249-016-0160-7","volume":"5","author":"AH Tekle","year":"2016","unstructured":"Tekle AH, Zoure HG, Noma M, Boussinesq M, Coffeng LE, Stolk WA, Remme JH. Progress towards onchocerciasis elimination in the participating countries of the African Programme for onchocerciasis control: epidemiological evaluation results. Infect Dis Poverty. 2016;5:66.","journal-title":"Infect Dis Poverty."},{"key":"574_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003664","volume":"9","author":"YE Kim","year":"2015","unstructured":"Kim YE, Remme JH, Steinmann P, Stolk WA, Roungou JB, Tediosi F. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa. PLoS Negl Trop Dis. 2015;9:e0003664.","journal-title":"PLoS Negl Trop Dis"},{"key":"574_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003113","volume":"8","author":"DS Evans","year":"2014","unstructured":"Evans DS, Alphonsus K, Umaru J, Eigege A, Miri E, Mafuyai H, et al. Status of onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in Central Nigeria: challenges in coordinating the stop MDA decision. PLoS Negl Trop Dis. 2014;8:e3113.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-019-0574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40249-019-0574-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-019-0574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:29:41Z","timestamp":1594682981000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-019-0574-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1186\/s40249-019-0574-0","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}